share_log

Investors in KuangChi Science (HKG:439) From Five Years Ago Are Still Down 61%, Even After 91% Gain This Past Week

Investors in KuangChi Science (HKG:439) From Five Years Ago Are Still Down 61%, Even After 91% Gain This Past Week

投资者在光启科学(HKG:439)五年前仍然亏损61%,即使在过去一周获得了91%的增长。
Simply Wall St ·  2024/10/04 06:57

It is doubtless a positive to see that the KuangChi Science Limited (HKG:439) share price has gained some 161% in the last three months. But don't envy holders -- looking back over 5 years the returns have been really bad. Indeed, the share price is down 61% in the period. Some might say the recent bounce is to be expected after such a bad drop. But it could be that the fall was overdone.

在过去的三个月中,光启科学有限公司(HKG:439)股价上涨了161%,这无疑是一个积极的迹象。但不要羡慕持有者们——回顾过去5年,回报确实非常糟糕。实际上,在此期间,股价下跌了61%。有人可能会说最近的反弹是在经历了如此大的暴跌后所能预期的。但也有可能是跌幅过大。

The recent uptick of 91% could be a positive sign of things to come, so let's take a look at historical fundamentals.

最近的上涨91%可能是未来发展的积极信号,因此让我们来看看历史基本面数据。

Given that KuangChi Science didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

考虑到光启科学在过去十二个月未盈利,我们将关注营业收入增长,以快速了解其业务发展情况。一般来说,没有盈利的公司预计每年都会增长营业收入,速度较快。正如你可以想象的,当快速的营业收入增长得以维持时,通常会导致快速的利润增长。

In the last five years KuangChi Science saw its revenue shrink by 2.8% per year. While far from catastrophic that is not good. The share price decline of 10% compound, over five years, is understandable given the company is losing money, and revenue is moving in the wrong direction. We don't think anyone is rushing to buy this stock. Ultimately, it may be worth watching - should revenue pick up, the share price might follow.

在过去五年中,光启科学的营业收入每年减少2.8%。虽然离灾难性还有一段距离,但也不算好。在过去五年中,股价下跌了10%,这是可以理解的,因为公司在亏损,而营业收入是朝着错误的方向发展。我们认为没有人会急于购买这支股票。最终,值得关注——如果营业收入增长,股价可能会跟随。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下面的图表显示了收益和营收随时间的变化情况(通过单击图像揭示确切的值)。

big
SEHK:439 Earnings and Revenue Growth October 3rd 2024
SEHK:439 2024年10月3日盈利和营收增长

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. Dive deeper into the earnings by checking this interactive graph of KuangChi Science's earnings, revenue and cash flow.

我们很高兴地报告,CEO的薪酬比同类公司的大多数CEO要低调。关注CEO的薪酬总是值得的,但更重要的问题是公司是否能在未来多年实现盈利增长。通过查看光启科学的营收、营业收入和现金流的互动图表,进一步了解盈利情况。

A Different Perspective

不同的观点

KuangChi Science shareholders are up 4.4% for the year. Unfortunately this falls short of the market return. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 10% endured over half a decade. So this might be a sign the business has turned its fortunes around. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for KuangChi Science you should know about.

光启科学的股东今年获利4.4%。不幸的是,这低于市场回报。然而,这仍然是一笔收益,绝对比过去半个世纪遭受的约10%年度亏损要好。因此,这可能是企业已扭转命运的迹象。尽管考虑市场状况对股价的各种影响非常值得,但有其他更重要的因素。例如,考虑风险。每家公司都有风险,我们发现了光启科学的两个警示信号,您应该知晓。

If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.

如果您像我一样,就不会希望错过这份免费的内部人士正在购买的低估小市值股票列表。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Hong Kong exchanges.

请注意,本文引用的市场回报反映了当前在香港证券交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发